[Karl Loren Note: It may, sometimes, be true that a drug is the best treatment. I start my advices with a preconception that there will always be something better than a drug. In this case my advice is similar to what it is for other so-called “hopeless diseases.”
I recommend a change in diet,
(http://www.karlloren.com/Diabetes/raw-food-diet.htm) a detoxification of the body,
(http://www.chelationtherapyonline.com/technical/p8.htm) and an examination of the wrong relationships
(http://www.chelationtherapyonline.com/anatomy/p5.htm) in the person’s life. Actual “treatments” should be done after these three senior factors are explored. I would then suggest topical and internal usage of MSM,
(http://www.bulkmsm.com/) including MSM cream, called Calm Cream
(http://www.bulkmsm.com/retailmsm/msmcream/index.html)and Life Glow Basic.
I believe that the above protocol will handle this situation completely.]
“Endometriosis is the most common cause of pelvic pain there is. So if a woman has pelvic pain she should begin by assuming she probably has endometriosis. “
Estimates of the numbers of women who suffer from endometriosis vary wildly. Some put the figure at 15% of women in their reproductive years. 10% is a more common guess.
Nearly 90 million women world-wide has been proposed as a conservative figure.
The fact is that there is no way to establish accurate figures because the only way to confirm a diagnosis is by a surgical procedure known as laparoscopy.
But if only 10% of women have it, that makes endometriosis one of the most common diseases on the face of the earth. More common than AIDS – more common than cancer.
Review of the video “Endometriosis. The Inside Story” By Heather Guidone
“Endometriosis: The Inside Story,” by E.B.Browne & M.M. Flores is, simply put, one of the best coping tools a woman and her family can have when dealing with Endometriosis.
“The Inside Story” shows us that we are not alone with this disease and that no one has to suffer in silence. Belle and Monica have done a wonderful job of showing the world how it is to live with Endometriosis – and how to get help managing it. Honest, educational, empowering and full of the latest information, no patient or doctor who treats this insidious disease should be without a copy of “The Inside Story” in their video library.
What is tamoxifen?
Tamoxifen (trade name Nolvadex) is a drug in pill form, taken orally, that interferes with the activity of estrogen (a female hormone). Tamoxifen has been used to treat both advanced and early stage breast cancer. It has been used for nearly 20 years to treat patients with advanced breast cancer. More recently, it also is being used as adjuvant, or additional, therapy following primary treatment for early stage breast cancer.
How does tamoxifen work in preventing or delaying breast cancer recurrence?
Some breast cancer cells are “estrogen sensitive.” In other words, estrogen binds to these cells and stimulates them to grow and divide. Tamoxifen prevents the binding of estrogen. This stops the cells from growing and in doing so, prevents or delays breast cancer recurrence. Tamoxifen is also known to work through growth factors and the immune system and may provide some benefit even in patients whose tumors are not estrogen sensitive.
A recent study published in The Lancet (May 16, 1998) found that taking tamoxifen for five years significantly reduces both breast cancer recurrence (42%) and mortality (22%) for all women. Results found that premenopausal women, not just postmenopausal women, and those whose breast cancer has spread to the local lymph glands benefit substantially from tamoxifen therapy.
Are there other beneficial effects of tamoxifen?
Although tamoxifen blocks the effect of estrogen on breast tissue, it acts like a weak estrogen in other body systems. This means that women who take tamoxifen may share some of the beneficial effects of taking estrogen replacement therapy, such as a decreased risk of osteoporosis and a decreased risk of heart disease.
What side effects should I expect from taking tamoxifen?
The most common side effect is hot flashes similar to those experienced during menopause. Tamoxifen may induce menopause in a woman who is close to menopause; however, it rarely does in young women. Other common side effects include vaginal dryness, irregular periods, and weight gain.
In addition, women taking tamoxifen may be at slightly increased risk of developing cataracts. Women who have cataracts before taking tamoxifen may be at slightly increased risk of needing eye surgery to remove the cataracts. There has NOT been a generalized decrease in vision in women taking tamoxifen. It is recommended that women taking tamoxifen have eye examinations by an opthalmologist at least every 2 years.
What is the risk of developing uterine cancer from taking tamoxifen?
Many experts believe tamoxifen may increase the risk of uterine cancer. There have been some reports of uterine cancer in women taking tamoxifen. However, the incidence is less than 1% in women taking doses of 20 mg daily. Most cancer specialists believe that the benefits of tamoxifen outweigh the risk of developing uterine cancer. However, all women using tamoxifen should have regular gynecological exams.
How long should I take tamoxifen?
Recent research comparing five years of adjuvant tamoxifen therapy with more than five years of tamoxifen has indicated that no additional benefit is obtained from extending the duration of tamoxifen therapy past five years. However, completing five years offers greater benefit than shorter durations of tamoxifen therapy. Additionally, the medical literature on adjuvant therapy shows benefits as long as 10 to 15 years after starting tamoxifen or 5 to 10 years after stopping it. Considering all the current research data, five years of tamoxifen therapy provides the optimum benefit.
What is the link between tamoxifen and depression?
Occasionally, women experience some of the same mood changes with tamoxifen that occur with any hormonal therapy. However, most patients experience no change in their mood as a result of taking tamoxifen.